New Norway Innovation Park opens

Monday, August 24, 2015

The Oslo Cancer Cluster Innovation Park in Norway has opened. A $122.8 million, public-private investment, the Innovation Park brings together the research, healthcare and industry partners in the Oslo oncology value chain with the Ullern High School.

[Read More]

Report: U.K. biotech pulling ahead in Europe

Monday, July 27, 2015

Over the past 10 years, the U.K. biotech sector has outperformed other European countries, raising $1.4 billion via IPOs and $2.4 billion in venture capital, according to a new report from life science market intelligence firm Evaluate and the U.K. BioIndustry Association (BIA). The rise in optimism has been most evident in 2014, with the momentum continuing into 2015.

[Read More]

Alexion Pharmaceuticals expands in Dublin, to add 200 jobs

Monday, May 11, 2015

Alexion Pharmaceuticals will significantly expand its operations in Ireland by constructing the company’s first ever biologics manufacturing facility outside the U.S. This $502.6 million, four-year project, which will be constructed at Alexion’s College Park site in Blanchardstown, is expected to create approximately 200 additional full-time jobs on completion, bringing Alexion’s total workforce in Ireland to almost 500.

[Read More]